Genome-wide promotor binding profiling of Protein phosphatase 1 and its major nuclear targeting subunits
Structural and functional characterization of the dual activity lipid phosphatase Synaptojanin 1 and its validation as a new drug target for intractable epilepsy
Protein phosphatase 2A PR130/B ''alpha 1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling
Potential of protein phosphatase inhibitor 1 as biomarker of pancreatic beta cell injury in vitro and in vivo
Disruption of protein phosphatase 1 complexes with the use of bioportides as a novel approach to target sperm motility
Crystal structure of the 5-phosphatase domain of Synaptojanin1 bound to its substrate diC8-PI(3,4,5)P3 in complex with a nanobody.